Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:35 PM
Ignite Modification Date:
2025-12-24 @ 10:35 PM
NCT ID:
NCT06242535
Eligibility Criteria:
Inclusion Criteria:
* Post-menopausal (\>1 year from last menstrual cycle) adult females (at birth) \>55 years of age with obesity (BMI ≥ 30)
Exclusion Criteria:
* Males
* Adults not females at birth
* Adult females diagnosed with Gout
* Adult females receiving hormone replacement therapy (HRT)
* Adult females who are currently prescribed or received weight loss medications within the past 6 months, or currently enrolled in a defined weight loss program.
* Adult females with cardio-metabolic disease \[e.g. cardiovascular disease (CVD), type 2 diabetes (T2DM), hypertension, h/o stroke etc.)\] requiring any prescription medication.
* Adult females with other chronic immune, pulmonary, neurodegenerative or systemic disease requiring prescription medication
* Adult females with severe asthma based upon American Thoracic Society (ATS) standards and/or NIH guidelines.
* Adult females requiring monoclonal antibody or biological treatment
* Adult females diagnosed with an acute lower respiratory or GI infection within 2 weeks
* Adult females who are pregnant (would not qualify as post-menopausal) or nursing mothers
* Adult females reporting moderate to severe mental or physical disability
* Adult females reporting unwillingness to travel to onsite clinical facilities
* Adult females with moderate to severe cognitive impairment
* Adult females diagnosed with an eating disorder
* Adult females on blood thinners and anti-platelet drugs (other than aspirin), on chronic steroids (including inhaled), on spironolactone, on statins, on diuretics, on chronic pain medications, on any medication that affects glucose, insulin, lipids, metabolic performance
* Adult females with any recent change in chronic disease or any recent change in medication.
* Adult females on supplements with potential to augment or compete with the GLY-LOW.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
56 Years
Study:
NCT06242535
Study Brief:
Protocol Section:
NCT06242535